Visgeneer Inc. (4197) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Visgeneer Inc. (4197:TWSE), powered by AI.

Current Price
$8.60
Sector
Healthcare
What is the Visgeneer Inc. stock price forecast?

Visgeneer Inc. is currently trading at $8.60. View real-time AI analysis on Alpha Lenz.

What is Visgeneer Inc. insider trading activity?

View the latest insider trading data for Visgeneer Inc. on Alpha Lenz.

What is Visgeneer Inc.'s P/E ratio?

View Visgeneer Inc.'s valuation metrics on Alpha Lenz.

Visgeneer Inc.

TWSE · 4197
NT$8.60-0.10(-1.15%)
Ask about Visgeneer Inc.'s future dividend policy...
Alpha Chat Insight

Visgeneer Inc.'s ROE is 2.7%. Explore profitability and growth together.

Ask for details

Company Overview

Visgeneer Inc. is a Taiwanese biotechnology company specializing in the development and manufacture of medical diagnostics and advanced skincare products. Established in 2005 and headquartered in Hsinchu, the company serves the global healthcare, medical device, and beauty markets. Its primary offerings include blood diagnostic equipment—such as glucose, cholesterol, ketone, and uric acid monitors—and test strips, recognized for their comprehensive features and international certifications (including CE, US FDA, ISO13485, and ISO15197), supporting both clinical and consumer health management. Visgeneer’s portfolio also extends to patented EU skincare solutions featuring zeaxanthin for anti-aging, and gene-based cancer diagnostics leveraging proprietary bioinformatics technology. With a notable presence across Asia, Europe, and other regions, Visgeneer supports hospitals, research institutions, and pharmaceutical distributors, and provides OEM and ODM contract manufacturing services. Awarded by Taiwan’s government for strategic innovation, Visgeneer continually contributes to global health solutions through product development and industry collaborations, solidifying its role as a leader in medical equipment and bioscience advancements.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$179.06MRevenue
0.00Shares Out
0Employees

Margins

38.20%Gross
4.55%EBITDA
-3.02%Operating
2.93%Pre-Tax
2.93%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

4.27%Rev 3Yr
0.35%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
-24.81%Net Inc 3Yr
54.14%Net Inc 5Yr

Returns

1.57%ROA
2.67%ROE
2.30%ROIC

Financial Health

NT$69.33MCash & Cash Equivalents
NT$66.61MNet Debt
68.28%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Visgeneer Inc. (ticker: 4197) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 8.6 with a P/E ratio of -x and P/B of -x.

ROE is 2.67% and operating margin is -3.02%. Annual revenue is $179M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Visgeneer Inc. (4197) Stock Forecast 2026 $8.60 — Price, Financials & Analyst Targets | Alpha Lenz